Cilostazol Tablet
Product Images NDC 70436-157

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Cilostazol (NDC 70436-157). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Slate Run Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure1 (Cilostazol Figure1)

This text appears to be a graph or chart showing the plasma concentration of three different compounds (Ciostazol, 5-dehydrociostazol, and trans-hydroxycilostazol) over a period of 2-3 hours. Therefore, no useful description can be created from this text alone.*

FDA Label Image

Chem-structure (Image 01)

FDA Label Image

Figure2 (Image 02)

FDA Label Image

70436-156-06 (Image 03)

FDA Label Image

70436-157-06 (Image 04)

This is a description of Cilostazol Tablets USP. Each tablet contains 100mg of Cilostazol USP and they are typically taken as prescribed by a healthcare provider. The tablets are coated and packaged in a way that keeps them safe from children. The manufacturer is Sate Run Pharmaceuticals and the product is distributed from Ohio. The text includes a variety of typographical errors and some text is not readable.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.